Hein Park Capital Management LP 13F: Quarter-over-Quarter Portfolio Changes
Hein Park Capital Management LP reported a disclosed portfolio value of approximately $50.2 million in its latest SEC Form 13F-HR filing for Q2 2026, down 18.1% quarter on quarter. Over the quarter, the fund initiated 1 new position and trimmed 1 holding.
Hein Park Capital Management LP's top buy was a new stake in Surgery Partners INC (SGRY) , equal to 35.7% of the disclosed portfolio. Its top sell was Caesars Entertainment INC Ne (CZR) . The fund sold 53.9% of its previously reported shares, reducing the position's portfolio weight by 35.7 percentage points.
New PositionsQ2 2026
Securities disclosed for the first time in Q2 2026 that were not present in the prior 13F-HR filing.
| Company | Ticker | Initial Portfolio Weight | History |
|---|---|---|---|
| SURGERY PARTNERS INC | SGRY | 35.7% | History → |
Top SellsQ2 2026
The fund's top sells among positions it retained in Q2 2026. Ranked by portfolio-weight impact. Full exits are listed separately.
| Company | Ticker | Portfolio Weight Change | Shares Sold | History |
|---|---|---|---|---|
| CAESARS ENTERTAINMENT INC NE | CZR | -35.7% | 53.9% | History → |
Net Portfolio Value ChangeQ2 2026
- $0.1BPrior quarter
- $0.1BCurrent quarter
- $-0.0BNet delta
- -18.1%% change
Methodology & FAQ
How Hein Park Capital Management LP Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for Hein Park Capital Management LP: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.
What stocks did Hein Park Capital Management LP buy in Q2 2026?
In Q2 2026, Hein Park Capital Management LP initiated 1 new position (SURGERY PARTNERS INC (SGRY)).
What stocks did Hein Park Capital Management LP sell in Q2 2026?
In Q2 2026, Hein Park Capital Management LP reduced holdings in CAESARS ENTERTAINMENT INC NE (CZR).
Which positions did Hein Park Capital Management LP initiate in Q2 2026?
Hein Park Capital Management LP established 1 new position in Q2 2026: SURGERY PARTNERS INC (SGRY, 35.7%).
Which existing positions saw the largest allocation increases for Hein Park Capital Management LP in Q2 2026?
Hein Park Capital Management LP reported no material allocation increases in existing positions in Q2 2026.
Which positions did Hein Park Capital Management LP fully exit in Q2 2026?
Hein Park Capital Management LP fully exited no positions in Q2 2026.
Which existing positions saw the largest allocation reductions for Hein Park Capital Management LP in Q2 2026?
Of 1 existing position with share-count reductions in Q2 2026, the largest were: CAESARS ENTERTAINMENT INC NE (CZR, -35.7% weight, -53.9% shares).
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.